Hims Hers Health News - May 11, 2026
🔴 HIMS is trading 10.1% down today after missing Q1 revenue estimates amid GLP-1 shift
HIMS is trading at $26.19 (-10.1%) in after-hours trading after the company missed Q1 2026 revenue estimates despite raising its full-year guidance. • Revenue...
Hims & Hers Missed Earnings Badly — Can a Guidance Raise and a Novo Nordisk Deal Rescue a Stock That Just Lost 6.8%?
Shares shifted sharply after Hims & Hers Health posted a first quarter that fell short on virtually every line that matters to Wall Street. Revenue came in at...
Hims & Hers first quarter 2026 revenue and EPS miss estimates amid a strategic shift to branded GLP-1s.
Hims & Hers reported first quarter 2026 revenue of $608.1 million, a 4% increase year-over-year, and a net loss per share of $0.40. Both figures fell short of...
🟢 HIMS is trading 5% up today ahead of Q1 earnings and weight-loss category updates
HIMS is trading at $29.73 (+5.18%) as investors position ahead of its Q1 2026 earnings report, scheduled for release after the market close on May 11. •...
🟢 HIMS is trading 4% up today ahead of Q1 earnings and weight-loss updates
HIMS is trading at $29.47 (+4.24%) ahead of its Q1 2026 earnings report and highly anticipated updates regarding its weight-loss category. • Analysts project...
🟢 HIMS is trading 5% up today ahead of Q1 earnings and weight-loss updates
HIMS is trading at $29.81 (+5%) in pre-market action, building on last week's 10% gain as investors anticipate the company's Q1 2026 earnings report scheduled...